12th International Congress on Myeloproliferative Neoplasms

 

12th International Congress on Myeloproliferative Neoplasms
J

28 y/o Female w/ Well-Differentiated Systemic Mastocytosis: Imatinib for Juxtamembrane / Wild-Type KIT Variants, and Well-Differentiated

By 12th International Congress on Myeloproliferative Neoplasms FEATURING Jason R. Gotlib
By 12th International Congress on Myeloproliferative Neoplasms FEATURING Jason R. Gotlib
15 views
November 25, 2019
Comments 0
Login to view comments. Click here to Login

Featured Video

16:26
Incyte

Effects of a Treatment Option on Hematocrit Control and Spleen Volum…

Feat. C. Harrison

Featured Video

16:51
Incyte

Effects of PV Treatment on White Blood Cell Count and Thrombotic Risk

Feat. C. Harrison
Cases
06:02

66 y/o Female w/ Aggressive Systemic Mastocytosis: AHNs Are Under-Di…

12th International Congress on Myeloproliferative Neoplasms

J. Gotlib

20 views
02:58

73 y/o Male w/ Aggressive Systemic Mastocytosis: High-Sensitive Assa…

12th International Congress on Myeloproliferative Neoplasms

J. Gotlib

12 views
03:11

73 y/o Male w/ SM-AHM: Work Through Whether SM or AHN Is the Major C…

12th International Congress on Myeloproliferative Neoplasms

J. Gotlib

14 views
04:59

68 y/o Female w/ Systemic Mastocytosis with Chronic Myelomonocytic L…

12th International Congress on Myeloproliferative Neoplasms

J. Gotlib

20 views
02:43

28 y/o Female w/ Well-Differentiated Systemic Mastocytosis: Imatinib…

12th International Congress on Myeloproliferative Neoplasms

J. Gotlib

15 views
07:53

66 y/o Female w/ Systemic Mastocytosis Associated with CEL: Clinical…

12th International Congress on Myeloproliferative Neoplasms

J. Gotlib

15 views